Printer Friendly

TARGETED GENETICS APPOINTS DIRECTOR OF DEVELOPMENT

 SEATTLE, June 21 /PRNewswire/ -- Targeted Genetics Corp. (TGC) announced today the appointment of Thomas C. Reynolds, M.D., Ph.D., as director of Development. In this new position, Reynolds will be responsible for developing both viral and non-viral gene delivery systems for clinical applications, validating modified patient cells and manufacturing of TGC's proprietary vectors.
 Prior to joining TGC, Reynolds was a research scientist at Somatix Therapy Corp.
 He received his M.D. and Ph.D. from Stanford University.
 Targeted Genetics Corp. is a leader in the development of integrated gene therapy treatments for acquired and inherited diseases. The company has begun its first Phase I trial, a gene therapy-based treatment for HIV infection.
 -0- 6/21/93
 /CONTACT: H. Stewart Parker or Alberta L. Garvin of Targeted Genetics, 206-623-7612/


CO: Targeted Genetics Corp. ST: Washington IN: MTC SU: PER

SW -- SE001 -- 3883 06/21/93 07:50 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 21, 1993
Words:148
Previous Article:J.R. SIMPLOT AND ENVIROGEN FORM COLLABORATIVE MARKETING ARRANGEMENT FOR ENVIRONMENTAL REMEDIATION
Next Article:UNIVAR CORP. ANNOUNCES IMPROVED FIRST-QUARTER EARNINGS
Topics:


Related Articles
TARGETED GENETICS ELECTS JAMES D. GRANT TO BOARD OF DIRECTORS
TARGETED GENETICS APPOINTS DIRECTOR OF CORPORATE DEVELOPMENT
DONALD L. MURFIN JOINS TARGETED GENETICS BOARD
TARGETED GENETICS NAMES BRUCE H. DEVENS DIRECTOR OF IMMUNOLOGY
Targeted Genetics Announces Conclusion of Joint Venture Relationship With Elan.
Targeted Genetics Reduces Long-Term Cash Obligations Through Conversion of Debt Into Equity.
New patent covers Targeted Genetics' approach to increase carrying capacity of AAV vectors.
Targeted Genetics Announces Todd E. Simpson to Step Down as Chief Financial Officer.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters